Rationale

The rapid evolution of artificial intelligence (AI) presents transformative potential for neuroscience, particularly in addressing complex challenges in basic research, in neurorehabilitation and the management of neurological and psychiatric disorders.

The Milan Center for Neuroscience (NeuroMi), aims to devote its seventh international meeting to these themes and to gather top scientists involved in basic, clinical and applied research to foster interdisciplinary collaboration, accelerate innovation, and ensure ethical, equitable deployment of AI technologies.

AI-driven tools offer unprecedented capabilities in diagnostics, promise personalized treatment planning, real-time monitoring, and predictive modelling of disease progression. These tools may favour treatment and rehabilitation in Stroke and traumatic brain injury, optimize diagnosis and interventions in disorders such as Alzheimer disease and Multiple Sclerosis, and support early detection and treatment of conditions like depression and schizophrenia.

However, to harness this potential, it is vital to bring together experts in neuroscience, AI, clinical practice, ethics, and policy to exchange knowledge, address challenges such as data privacy and algorithmic bias, and define global strategies.

This meeting aims to catalyse impactful research, promote best practices, and align technological advances with clinical needs and societal values.

The Milan Center for Neuroscience (NEUROMI) was founded in 2014 to gather Neuroscientists from 7 different Departments of University of Milano-Bicocca and now counts more than 500 neuroscientists from research institutions of the large Milan area. Its mission is to promote multidisciplinary research in the field of neuroscience, to foster collaborations among various disciplines, to share technological platforms and to offer top-level education in neuroscience.